Improved menstrual pattern · adolescent women with PCOS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acne ‐ Visual analogue scale or Clinical acne score · adolescent women with PCOS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Body‐mass index (BMI) · adolescent women with PCOS
1 finding from 1 review
Minor adverse events · adult women with PCOS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improved menstrual pattern · adult women with PCOS
1 finding from 1 review
Acne ‐ Visual analogue scale or Clinical acne score · adult women with PCOS
1 finding from 1 review
Body‐mass index (BMI) · adult women with PCOS
1 finding from 1 review
Live birth rate per woman ‐ long protocol GnRH‐agonist · women with polycystic ovary syndrome
Metformin showed no clear difference in live birth rate per woman ‐ long protocol GnRH‐agonist compared with placebo or no treatment (low certainty).
1 finding from 1 review
Live birth rate per woman ‐ short protocol GnRH‐antagonist · women with polycystic ovary syndrome
Metformin may leads to lower live birth rate per woman ‐ short protocol GnRH‐antagonist compared with placebo or no treatment (low certainty).
1 finding from 1 review
OHSS · women with polycystic ovary syndrome
Metformin may leads to lower incidence of OHSS per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Clinical pregnancy rate per woman ‐ long protocol GnRH‐agonist · women with polycystic ovary syndrome
Metformin may leads to higher clinical pregnancy rate per woman ‐ long protocol GnRH‐agonist compared with placebo or no treatment (low certainty).
1 finding from 1 review
Side effects per woman · women with polycystic ovary syndrome
Metformin may leads to higher side effects per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Live birth rate per woman · women with polycystic ovary syndrome
Metformin showed no clear difference in live birth rate per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Miscarriage rate per woman aParticipants with BMI < 30 kg/2 · women with polycystic ovary syndrome
Metformin showed no clear difference in miscarriage rate per woman aParticipants with BMI < 30 kg/2 compared with clomiphene citrate (low certainty).
1 finding from 1 review
Miscarriage rate per woman aParticipants with BMI ≥ 30 kg/m2 · women with polycystic ovary syndrome
Metformin showed no clear difference in miscarriage rate per woman aParticipants with BMI ≥ 30 kg/m2 compared with clomiphene citrate (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · women with polycystic ovary syndrome
Metformin probably leads to higher adverse events (gastrointestinal) per woman compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Ovulation rate · women with polycystic ovary syndrome
Metformin may leads to higher ovulation rate per woman compared with placebo or no treatment (low certainty).
1 finding from 1 review
Large‐for‐gestational age · women with obesity during pregnancy
Metformin showed no clear difference in large‐for‐gestational‐age infant, defined as birthweight ≥ 90th… compared with placebo (high certainty).
1 finding from 1 review
Gestational weight gain · women with obesity during pregnancy
1 finding from 1 review
Hypertensive disorders of pregnancy: gestational hypertension · women with obesity during pregnancy
Metformin showed no clear difference in gestational hypertension compared with placebo (low certainty).
1 finding from 1 review